Supplementary Table 4 from Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
Table S1. Specific mutations of genes listed in Table 1. Table S2. Foundation Medicine sequencing calls of cancer-specific gene panel. Table S3. Gene lists corresponding to microarray analysis describ
Supplementary Table 2. Antibodies and dilutions used in Cyclic Immunofluorescence (CyCIF) with vendor, catalogue number, and dilution used for each marker.
